By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cardioxyl Pharmaceuticals 

Towson  Maryland    U.S.A.
Phone: Fax:



Start Up

Company News
Strong in Immune-Oncology, Bristol-Myers Squibb (BMY) Branches into Cardiac Meds, Buys Cardioxyl for $2 Billion 11/2/2015 6:14:39 AM
Cardioxyl Pharmaceuticals HNO Prodrugs Show Effectiveness In Preclinical Models Following Oral Administration, Improve Hemodynamics In Chronic Diastolic Dysfunction 11/20/2014 12:36:29 PM
Cardioxyl Pharmaceuticals Presents Oral Heart Failure Treatment Data For Its Experimental HNO Prodrug At HFSA 18th Annual Scientific Meeting 9/16/2014 12:49:54 PM
Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 7/28/2014 8:05:34 AM
New Findings Published in Circulation: Heart Failure Show Potential Utility of Cardioxyl Pharmaceuticals's HNO Donors as Novel Treatments for Heart Failure 10/28/2013 10:58:44 AM
Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., as Chief Medical Officer 9/11/2013 6:47:04 AM
Cardioxyl Pharmaceuticals Raises $28 Million in Venture Funding 11/8/2012 9:07:45 AM
Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session 4/5/2011 6:53:14 AM
Cardioxyl Pharmaceuticals Presents Data on its Clinical Candidate, Cxl-1020, at the 60th Annual American College of Cardiology Scientific Session 4/4/2011 2:23:51 PM
Cardioxyl Pharmaceuticals Strengthens Executive Team by Appointing James Gilbert, M.D., as Chief Medical Officer 1/11/2011 6:42:29 AM